
Dropprint Genomics YCアプリケーション
Dropprint GenomicsはWinter 2020バッチでHealthcare企業としてY Combinatorを卒業しました。以下:会社の事業内容、創業者、そして実際のYCフォームで質問ごとに再構築されたYCへの応募内容。
- YCバッチ
- Winter 2020
- 業界
- HealthcareDrug Discovery and Delivery
- チーム規模
- 2
- ステータス
- Acquired
- ローンチ済み
- 2020
創業者
Rachel GateFounder
Meena SubramaniamFounder
Jimmie YeFounder
Dropprint Genomicsの事業内容
Who we are? We write software that understands the activity of individual cells as opposed to all cells. This approach is novel because we are no longer looking at average signals and can be precise. It is like a police person trying to identify the speeding car, they won’t find it if they look at all the cars at once, rather they need to look at the speed of each individual car. This is the beauty of single cell genomics, we can now identify that speeding car. Why now? The biggest barrier for entry into the single cell genomics market are cost and data analysis. To that end, we have reduced the cost by 10-fold and built the computational infrastructure for scalability. Although single cell sequencing has only been around for about five years, we come from one of the top single cell genomics labs and were the first to process and analyze millions of immune cells. Thanks to our software solutions, we have been able to bring big data solutions to the immune system. Where are we and where are we going? We have generated a database of over 1 million immune cells spanning healthy, cancerous, and autoimmune immune cells and are growing through paid partnerships. Harnessing out database and ML software, we can take a data-centric approach for better target discovery. Fortunately, as our database continues to grow, our models will continue to learn for more precise, unbiased, and automated single cell genomics. Thank you!
Dropprint GenomicsのYCアプリケーション、再構築済み
Y Combinator 申請
Dropprint Genomics 様、Winter 2020 バッチ。公開データから回答された、実際のフォームの質問。
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
Dropprint Genomics
The better way to run single cell genomics
We build software that analyzes the activity of individual cells rather than bulk cell populations. Our product reduces the cost of single cell genomics by 10-fold and supports scalable computational infrastructure. Researchers and companies use our platform to process and analyze millions of immune cells, enabling precise identification and characterization of cells in healthy, cancerous, and autoimmune contexts.
We live and work in San Francisco, CA, and the company will continue to be based there after YC.
San Francisco is where our team lives and where single cell genomics research and biotech companies concentrate, making it easier to work closely with early partners and stay connected to the industry.
よくある質問
Dropprint Genomicsの実際のYCアプリケーションですか?
いいえ。Y Combinatorは提出されたアプリケーションを非公開にしています。これは再構築されたものです。実際のYCフォームの質問に、Dropprint Genomicsの公開データ(ローンチノート、創業者経歴、製品説明)から回答しています。Dropprint Genomicsのような会社がYCにどのようにアピールするかを示しており、彼らが提出したテキストではありません。
Dropprint GenomicsはどのYCバッチに参加しましたか?
Dropprint GenomicsはY CombinatorのWinter 2020バッチに参加しました。
Dropprint Genomicsは誰によって設立されましたか?
Dropprint GenomicsはRachel Gate, Meena Subramaniam, Jimmie Yeによって設立されました。
Dropprint Genomicsは何をしていますか?
The better way to run single cell genomics
完全な再構築されたアプリケーションはどのように読めばよいですか?
無料のRound Fundedアカウントを作成してください。 Dropprint Genomicsの26つの回答からなる完全なアプリケーションと、他のすべてのYCバッチはYC Insightsにあります。